Got out o'here a while ago. Realised the tech was tricky and not fully understood with real manufacture, storage and administration issues for to be bigger than niche. Shotgun approach to clinical applications just indicates a whole bunch of fishing expeditions. Then big pharma balls-up and now a class action plus unimpressive FDA interactions Where's the good news?
Great Company, Great Future!, page-49
-
- There are more pages in this discussion • 33 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.32 |
Change
0.000(0.00%) |
Mkt cap ! $1.478B | |||
| Open | High | Low | Value | Volume |
| $1.31 | $1.32 | $1.28 | $1.008M | 777.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 23 | 56148 | $1.32 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.32 | 19550 | 8 |
View Market Depth
| Last trade - 12.36pm 01/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |